Talis Biomedical Corporation
TLIS
$1.60
-$0.08-4.76%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 59.87M | 70.34M | 76.73M | 88.00M | 98.20M |
| Total Receivables | -- | 6.00K | 50.00K | 5.00K | 532.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.73M | 827.00K | 901.00K | 1.53M | 2.22M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 1.01M |
| Total Current Assets | 63.60M | 71.17M | 77.68M | 89.53M | 101.97M |
|
|
|||||
| Total Current Assets | 63.60M | 71.17M | 77.68M | 89.53M | 101.97M |
| Net Property, Plant & Equipment | 8.33M | 9.78M | 15.45M | 16.15M | 19.57M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 766.00K | 1.54M | 1.54M | 1.54M | 1.54M |
| Total Assets | 72.70M | 82.49M | 94.67M | 107.23M | 123.08M |
|
|
|||||
| Total Accounts Payable | 3.79M | 3.62M | 1.34M | 2.70M | 2.49M |
| Total Accrued Expenses | 1.48M | 2.95M | 4.55M | 2.89M | 4.04M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.92M | 2.90M | 2.88M | 2.86M | 2.74M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 8.20M | 9.47M | 8.77M | 8.45M | 9.26M |
|
|
|||||
| Total Current Liabilities | 8.20M | 9.47M | 8.77M | 8.45M | 9.26M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 15.88M | 16.34M | 16.79M | 17.22M | 17.65M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 24.07M | 25.81M | 25.56M | 25.67M | 26.91M |
|
|
|||||
| Common Stock & APIC | 610.47M | 609.68M | 609.07M | 608.05M | 606.98M |
| Retained Earnings | -561.85M | -553.00M | -539.96M | -526.50M | -510.82M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 48.62M | 56.68M | 69.11M | 81.55M | 96.16M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
|
|
|||||
| Total Common Equity | 48.62M | 56.68M | 69.11M | 81.55M | 96.16M |
| Total Preferred Equity | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 48.63M | 56.68M | 69.12M | 81.56M | 96.17M |
|
|
|||||
